382 related articles for article (PubMed ID: 20581395)
1. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
Liu J; Afroza H; Rader DJ; Jin W
J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
[TBL] [Abstract][Full Text] [Related]
2. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
3. Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes.
Essalmani R; Susan-Resiga D; Chamberland A; Asselin MC; Canuel M; Constam D; Creemers JW; Day R; Gauthier D; Prat A; Seidah NG
J Biol Chem; 2013 Sep; 288(37):26410-8. PubMed ID: 23918928
[TBL] [Abstract][Full Text] [Related]
4. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage.
Jin N; Matter WF; Michael LF; Qian Y; Gheyi T; Cano L; Perez C; Lafuente C; Broughton HB; Espada A
ACS Chem Biol; 2021 Mar; 16(3):457-462. PubMed ID: 33656326
[TBL] [Abstract][Full Text] [Related]
5. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
[TBL] [Abstract][Full Text] [Related]
6. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.
Lei X; Shi F; Basu D; Huq A; Routhier S; Day R; Jin W
J Biol Chem; 2011 May; 286(18):15747-56. PubMed ID: 21398697
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
9. GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice.
Li X; Zhang Y; Zhang M; Wang Y
Sci Rep; 2020 Sep; 10(1):16168. PubMed ID: 32999434
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
[TBL] [Abstract][Full Text] [Related]
11. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes.
Dijk W; Ruppert PMM; Oost LJ; Kersten S
J Biol Chem; 2018 Sep; 293(36):14134-14145. PubMed ID: 30021841
[TBL] [Abstract][Full Text] [Related]
13. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
[TBL] [Abstract][Full Text] [Related]
14. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lipoprotein lipase by Angptl4.
Dijk W; Kersten S
Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
[TBL] [Abstract][Full Text] [Related]
16. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
[TBL] [Abstract][Full Text] [Related]
17. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.
Lichtenstein L; Kersten S
Biochim Biophys Acta; 2010 Apr; 1801(4):415-20. PubMed ID: 20056168
[TBL] [Abstract][Full Text] [Related]
18. In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.
Montavoci L; Ben Mariem O; Saporiti S; Laurenzi T; Palazzolo L; Ossoli AF; Guerrini U; Calabresi L; Eberini I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542527
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
[TBL] [Abstract][Full Text] [Related]
20. Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1.
Gin P; Goulbourne CN; Adeyo O; Beigneux AP; Davies BS; Tat S; Voss CV; Bensadoun A; Fong LG; Young SG
Hum Mol Genet; 2012 Jul; 21(13):2961-72. PubMed ID: 22493000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
